Attention Users of the Blood Pressure Drug Benicar®
Benicar® is a prescription medication that is used to treat high blood pressure. It is dispensed in the form of a pill that is ingested orally. The primary ingredient of Benicar® is “Olmestartan”, which makes it similar to other medications such as, Benicar HCT, Tribenzor, and Azor. We are accepting cases that involve all 4 of these drugs that are pro-Olmestartan Medoxomil.
The first use of the drug must have occurred on or before May 1, 2015, and the client must have used one of these products for 30 days or longer.
Benicar® is manufactured by a Japanese company called Daiichi Sanyo, and is the 10th most prescribed medication in the United States.
Studies have shown that patients who take Benicar® or other Olmesartan products are more likely to become hospitalized for severe intestinal conditions than patients who consumed other blood pressure medications. Severe intestinal conditions include chronic diarrhea, malabsorption of nutrients, weight loss of 5% or more of total body weight, abdominal pain, vomiting, and nausea. These conditions arise as a result of the active ingredient in the drug that kills the healthy blood cells in the small intestine. Certain patients require hospitalization due to the severity of the illness. Alternatively, some people require treatment from a primary care physician or a gastrointestinal specialist. Clients in more severe cases may have been diagnosed with celiac disease, gluten sensitivity, colitis, or enteropathy.
We are currently accepting cases in which the client received treatment from a doctor or hospital for chronic diarrhea. This is a symptom that accompanies more serious medical conditions such as colitis or celiac disease. Anti-diarrheal medications alone are not a sufficient requirement, the client must have received treatment from a physician.
Benicar® Litigation Deadline
If you or a loved one took Benicar® prior to May of 2015 and had medical treatment for diarrhea you may be entitled to commpensation. You must contact us as soon as possible as the deadline for signing new cases is August 22, 2017. Call us at 1-800-CALL-KEN.